Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AiRuiKang Medical Investment Management (Beijing) is a Chinese healthcare-focused investment and management firm. The company specializes in the acquisition, restructuring, and operational management of medical institutions, particularly hospitals and specialized clinics. It aims to integrate high-quality medical resources and improve healthcare delivery through professional management and capital investment. AiRuiKang also explores opportunities in medical technology and healthcare services to build a comprehensive medical ecosystem. The firm is recognized for its role in the modernization and professionalization of hospital operations within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AiRuiKang Medical Investment Management (Beijing).